Skip to main content
The Egyptian Journal of Otolaryngology

Table 5 Response to sclerotherapy according to sclerosing agents

From: Cervicofacial lymphatic malformations: diagnosis and management

Sclerosing agent

Study(ies)

First author

Average Nbr of injections

Overall response

OK-432

Giguère [11], Yoo [22], Horbach [19]

2

83.5–96%

Bleomycin

Horbach [19]

3–4

70–100%

Doxycycline

Horbach [19]

1–1.6

67–100%

Ethibloc

Emran [23]

1–6

77–84%

Polidocanol

Horbach [19]

2–3

90–100%

Absolute ethanol

Horbach [19]

Not reported

68–100%

Back to article page